ESCRS - A summary of 77 important trials

A summary of 77 important trials

A summary of 77 important trials

Leigh Spielberg

Published: Wednesday, December 4, 2019

“Do you always have the latest evidence-based medicine at your fingertips?” This is the challenge posed by Current Clinical Evidence in Ophthalmology (Kugler), edited by Drs Roberts, Gale & Martin. This book summarises 77 important trials in ophthalmology, offering all the information needed for a clinician to make informed decisions. Organised by subspecialty (anterior segment, glaucoma, retina, neuro-ophthalmology and paediatric ophthalmology), each section includes the studies judged by the editors to be the most relevant at this time. Each study is summarised on two pages, with information such as study design, evidence level, aims, methods, results, weakness and “key messages” provided. The book was designed for busy clinicians and trainees sitting specialist examinations, and could certainly be useful for ophthalmology researchers.

Tags: clinical evidence ophthalmology

Latest Articles

Diamonds in the Rough

The push for inclusivity in ophthalmology.

Making Female Leadership More than a Moment

A remarkable global confluence of women in key positions.

ESCRS Talks Technology at AAO

Europe adopts technological advances, US still waiting for lenses and lasers.

Sorting Out Simultaneous Vision IOLs

The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.

Big Advantages to Small-Aperture IOLs

Small-aperture IOLs offer superior image quality with increased range of focus.

Prioritising Self-Care

Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.

Valuing Clinical Trial Design

How inclusivity and diversity can enhance scientific accuracy in research.

Knowing Iris Repair: Using Iridodiathermy in Iris Surgery

Prepare for decentred pupils and uneven irides in multiple situations.

Neuroprotectant Treatment for MacTel Type 2

Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.

Supplement: Maximizing Visual Quality in Refractive Surgery Through Enhanced Precision and Safety